Newsfile
Search documents
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KMX
Newsfile· 2025-11-14 21:52
Core Viewpoint - Rosen Law Firm is encouraging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from June 20, 2025, to November 5, 2025 [1][5]. Group 1: Class Action Details - Investors who purchased CarMax securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 2, 2026 [3][6]. - The lawsuit alleges that CarMax's defendants made materially false statements regarding the company's growth prospects, which were overstated due to temporary market conditions [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked highly for its number of securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - The founding partner of Rosen Law Firm was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and reputation in the field [4].
K9 Gold Corp. Closes 2nd Tranche of PP
Newsfile· 2025-11-14 21:45
Core Points - K9 Gold Corp. has successfully closed the second tranche of its non-brokered private placement, raising a total of $100,000 by issuing 400,000 units at a price of $0.25 per unit [1][2] - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of an additional common share at $0.35 for two years [2] - The offering is subject to a statutory hold period of four months and one day, and no insiders participated in this tranche [3] Marketing and Investor Awareness - The company entered into a marketing and investor awareness agreement with Capitaliz for a total fee of $200,000, which includes an increase in services [4] - Payment for the services was made from the company's existing general working capital [4] Company Overview - K9 Gold Corp. is focused on mineral exploration in North America, with its primary asset being the Trinity Silver Project in Nevada, covering approximately 14,523 acres [5] - The company is listed on the TSX Venture Exchange [5]
MRX DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRX
Newsfile· 2025-11-14 21:29
Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a securities class action related to misleading financial statements and practices [1][5]. Group 1: Class Action Details - The class period for the securities class action is from May 16, 2024, to August 5, 2025 [1]. - Investors who purchased Marex securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the lead plaintiff deadline of December 8, 2025 [3]. Group 2: Allegations Against Marex - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements among subsidiaries [5]. - It is claimed that Marex's financial statements could not be relied upon due to these issues, leading to misleading positive statements about the company's business and operations [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Many attorneys at Rosen Law Firm have received recognition from Lawdragon and Super Lawyers, emphasizing the firm's expertise in this area [4].
Stonegate Capital Partners Updates Coverage on Aquafil Group (ECNL) Q3 2025
Newsfile· 2025-11-14 21:20
Core Insights - Aquafil Group (MI: ECNL) demonstrated resilient profitability in Q3 2025 despite softer top-line trends, benefiting from efficiency measures and cost control [1] - The company achieved an EBITDA margin of 13.7%, an increase from 12.1% in Q3 2024, driven by lower raw material costs and a richer mix of regenerated products [1][6] - ECONYL®-branded and other regenerated fibers accounted for approximately 60% of fiber revenues year to date, highlighting their importance to the company's revenue stream [1][6] Financial Performance - EBITDA margin improved to 13.7% in Q3 2025 from 12.1% in Q3 2024, indicating effective cost management and operational efficiency [1][6] - The North American BCF business showed solid volume gains, contributing significantly to growth, while EMEA performance was stable compared to the previous year [1] Strategic Initiatives - Management is advancing the reorganization of U.S. carpet collection and recycling operations, which includes recognizing one-off restructuring charges [1] - The restructuring is expected to lead to lower labor and logistics costs in FY26 and beyond, positioning the company for improved margins [1][6] Market Dynamics - The Asia Pacific region remained soft, particularly in textile applications, indicating potential challenges in that market segment [1]
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
Newsfile· 2025-11-14 21:19
Core Insights - Elite Pharmaceuticals, Inc. reported consolidated revenues of $36.3 million for the second quarter of fiscal year 2026, marking an increase of $17.4 million or approximately 92% compared to the same period in the previous fiscal year [2] - Income from operations reached $8.2 million, an increase of $4.7 million or approximately 136% year-over-year, primarily driven by sales of lisdexamfetamine products and strong growth in Elite's product lines [2] Financial Performance - The significant revenue growth of 92% is attributed to the successful launch of new products and overall strong performance in the company's product lines [2] - The increase in income from operations reflects improved operational efficiency and market demand for Elite's niche generic products [2] Conference Call Information - A conference call is scheduled for November 17, 2025, at 11:30 AM EST to discuss the financial results and recent business developments [3][4] - Stakeholders are encouraged to submit questions in advance of the call [3]
Tsodilo Resources Intends to Pursue Re-Domiciliation to United States
Newsfile· 2025-11-14 21:15
Core Viewpoint - Tsodilo Resources Limited plans to re-domicile to the United States, reflecting a strategic shift as a majority of its shareholders are based outside Canada [1]. Company Overview - Tsodilo Resources Limited is an international resource exploration company focused on discovering economic metal deposits in Botswana, holding a 100% stake in the Gcwihaba project area, which includes five prospecting licenses for various metals [2].
Colibri Provides Summary of Over-Subscribed Non-Brokered Private Placement
Newsfile· 2025-11-14 21:11
Core Viewpoint - Colibri Resource Corporation has successfully completed an over-subscribed non-brokered private placement, raising a total of C$1,491,702 to fund exploration projects in Mexico and for general working capital [1][3][6]. Summary by Sections Offering Details - The Offering consisted of units, each comprising one common share and one common share purchase warrant, with warrants priced at C$0.25 for a period of 24 months [2]. - The Offering was completed in two tranches: the first tranche closed on October 31, 2025, issuing 9,004,816 units for gross proceeds of C$1,350,722, and the second tranche closed on November 5, 2025, issuing 939,867 units for gross proceeds of C$140,980 [3]. Financial Aspects - The total gross proceeds from both tranches amounted to C$1,491,702 [3]. - The Company agreed to pay finder's fees totaling C$71,504 and issue 476,693 non-transferable finder's warrants, also priced at C$0.25 for a period of 24 months [4]. Management Participation - Ian McGavney, the director and CEO, purchased 269,000 units for C$40,350, which is classified as a related party transaction but is exempt from formal valuation and minority shareholder approval due to its size relative to the Company's market capitalization [5]. Use of Proceeds - Net proceeds from the Offering will be allocated to exploration at Colibri's flagship gold projects in Mexico, specifically the Pilar and EP projects, as well as for general working capital [6]. Company Overview - Colibri Resource Corporation is a Canadian junior mining company focused on the acquisition, exploration, and development of precious metal properties in Sonora, Mexico, holding a 100% interest in the EP Gold Project and a 49% joint venture interest in the Pilar Gold & Silver Project [7].
Stinger Resources Inc. Announces Cancellation of Incentive Stock Options
Newsfile· 2025-11-14 21:05
Company Overview - Stinger Resources Inc. holds interests in gold and silver properties in British Columbia, including the 100% owned past producing Dunwell Mine located near Stewart in the "Golden Triangle" [2] - The company also owns a 100% interest in the Gold Hill property near Fort Steele and the Silver Side property, along with an optioned interest in the Ample Goldmax property in other areas of British Columbia [3] Recent Developments - Effective November 13, 2025, Stinger Resources has cancelled a total of 707,000 incentive stock options that were previously granted on March 19, 2021, with an exercise price of $0.195 [1]
Telix Pharmaceuticals Ltd. (TLX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of January 9, 2026 Deadline
Newsfile· 2025-11-14 21:02
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Telix Pharmaceuticals Ltd. (NASDAQ: TLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=177498&wire=5&utm_campaign=1or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
Levi & Korsinsky Urges Primo Brands Corporation / Primo Water Corporation (PRMB) Shareholders to Act Before Lead Plaintiff Deadline January 12, 2026
Newsfile· 2025-11-14 20:54
Levi & Korsinsky Urges Primo Brands Corporation / Primo Water Corporation (PRMB) Shareholders to Act Before Lead Plaintiff Deadline January 12, 2026November 14, 2025 3:55 PM EST | Source: Levi & Korsinsky, LLPNew York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Primo Brands Corporation / Primo Water Corporation (NYSE: PRMB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:h ...